VINORELBINE SANDOZ 20 mg, soft capsule capsule
Active ingredients: Vinorelbine L-tartrate, Vinorelbine
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsulecapsuleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VINORELBINE SANDOZ 20 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium papier avec fermeture de sécurité enfant de 1 capsule(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Mar 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69684369CIP73017726CIP133400930177266Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VINORELBINEcapsule | 20 mg · une capsule | FT |
| TARTRATE DE VINORELBINEcapsule | 27,70 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.